Document is current
Any future updates will be listed below
-
Authors
Haney, Margaret
Vallée, Monique
Fabre, Sandy https://orcid.org/0000-0002-8850-0901
Collins Reed, Stephanie https://orcid.org/0000-0002-6269-308X
Zanese, Marion https://orcid.org/0000-0002-0521-517X
Campistron, Ghislaine
Arout, Caroline A.
Foltin, Richard W.
Cooper, Ziva D. https://orcid.org/0000-0001-8001-2332
Kearney-Ramos, Tonisha
Metna, Mathilde
Justinova, Zuzana https://orcid.org/0000-0001-5793-7484
Schindler, Charles https://orcid.org/0000-0001-7911-9116
Hebert-Chatelain, Etienne
Bellocchio, Luigi
Cathala, Adeline
Bari, Andrea
Serrat, Roman
Finlay, David B.
Caraci, Filippo https://orcid.org/0000-0002-9867-6054
Redon, Bastien
Martín-García, Elena https://orcid.org/0000-0002-4487-3028
Busquets-Garcia, Arnau https://orcid.org/0000-0002-7100-8873
Matias, Isabelle
Levin, Frances R.
Felpin, François-Xavier
Simon, Nicolas
Cota, Daniela https://orcid.org/0000-0002-6909-2156
Spampinato, Umberto
Maldonado, Rafael https://orcid.org/0000-0002-4359-8773
Shaham, Yavin https://orcid.org/0000-0002-8242-3319
Glass, Michelle
Thomsen, Lars Lykke https://orcid.org/0000-0001-5788-6867
Mengel, Helle
Marsicano, Giovanni https://orcid.org/0000-0003-3804-1951
Monlezun, Stéphanie
Revest, Jean-Michel https://orcid.org/0000-0001-6459-0888
Piazza, Pier Vincenzo https://orcid.org/0000-0002-6101-9691
- License Information
-
More Information
Article History
Received: 10 November 2022
Accepted: 1 May 2023
First Online: 8 June 2023
Competing interests
: P.V.P., S.M., S.F., M.M., R.M., U.S. and H.M. are stockholders of Aelis Farma. M.V., J.-M.R., D.C. and G.M. are stockholders of and consultants for Aelis Farma. M.Z., G.C., L.L.T., A.B. and R.S. have stock options of Aelis Farma. M.G. is a consultant of Aelis Farma. P.V.P., M.V., F.X.F., J.-M.R. and S.F. are inventors on a composition-of-matter patent application (patent family WO2014/083068) that covers AEF0117. P.P.V., S.F., M.M., S.M., A.B.-G., D.C., G.M., J.-M.R. and M.V. are inventors on a method-of-use patent application (patent family WO2019/162328) that covers use of AEF0117 for the treatment of cannabinoid-related disorders. M.H. is a stockholder and on the Scientific Advisory Board of Pleo Pharma. The remaining authors declare no competing interests.
